《本地樓市》泛海國際(00129.HK) 洪水橋匯都加推63伙 料農曆新年前推售
泛海國際(00129.HK) 洪水橋住宅發展項目「high park匯都」推出第3號價單,涉及單位63伙,折實平均呎價11,797元,當中2座樓王單位共58伙,以及5個位於第3座的三房戶,折實售價339.7萬元起,最低折實呎價10,288元。泛海國際集團執行董事關堡林預計,這批單位將在農曆新年前推售。
他續指,項目自去年7月推出至今已累售92個單位,成交金額逾5.2億元。今日公布的第3號價單,會提供四項付款辦法,樓價折扣會直接在成交價中反映,優惠介乎樓價8%至14.5%不等,而96伙在第1B號價單及第2B號價單內的單位,則維持原有的現金回贈優惠。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.